Refuah Solutions is a software provider focused on the clinical trial space. Its website emphasizes that its clinical trial software is designed with input from experienced researchers as well as the patients it serves. The product naming suggests a focus on three main roles: researchers, patients, and healthcare professionals, indicating a positioning around collaboration across clinical research workflows.
The currently identifiable modules include PI-Support, Patient-Empower, and HCP-Integrate. Judging by their names, they appear to cover principal investigator support, patient engagement/empowerment, and healthcare professional integration. However, the available website text does not provide a detailed feature list—such as participant recruitment, e-consent, data collection, follow-up management, reporting and analytics, or compliance auditing—so its actual capability boundaries cannot be further confirmed.
Publicly available information does not disclose plans, pricing, a free version, or trial availability. It also does not clarify whether the product is delivered as cloud SaaS, private deployment, or a hybrid model. For clinical trial software, third-party system integration, APIs, permission controls, audit logs, and data security compliance are all critical, but the current materials do not provide details on these areas. During procurement evaluation, buyers should specifically confirm whether it supports integration with systems such as EDC, CTMS, ePRO, and EMR/EHR, and whether it meets clinical research and healthcare data compliance requirements in the relevant region.
Its strength lies in its vertical focus: it is dedicated to clinical trials and highlights participation from real-world users in the design process, which may in theory make it more aligned with researcher and patient needs. The drawbacks are also clear: there is too little public information to assess product maturity, customer scale, service support, data security, or scalability. Enterprise buyers should conduct thorough due diligence and request a full demo before procurement.
It is better suited for pharmaceutical companies, CROs, and hospital research teams that are initially exploring clinical trial participant collaboration tools, patient experience tools, or researcher support systems. Access from China is unknown, and payment methods are not disclosed. If deploying or using it in China, buyers should also pay attention to cross-border access stability, outbound transfer of medical data, payment arrangements, and the contracting entity. Alternatives to compare include Medidata, Veeva Vault Clinical, Castor, REDCap, and Oracle Clinical One.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on refuahsolutions.com official site.
refuahsolutions.com is an Unknown SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach refuahsolutions.com directly.